Multiorgan gadolinium (Gd) deposition and fibrosis in a patient with nephrogenic systemic fibrosis - An autopsy-based review

Nephrology Dialysis Transplantation

Volumn 26, Issue 11, 2011, Pages 3616-3626

  Sanyal, Soma ^a   Marckmann, Peter ^b   Scherer, Susanne ^c   Abraham, Jerrold L ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

calcification; gadolinium; nephrogenic systemic fibrosis; renal failure; SEM EDS

Indexed keywords

GADOLINIUM;

ABDOMINAL ABSCESS; ADULT; ARTICLE; AUTOPSY; CALCIFICATION; CALCIUM BLOOD LEVEL; CASE REPORT; CEREBELLUM; CHRONIC KIDNEY FAILURE; CLINICAL FEATURE; CONCENTRATION RESPONSE; CONTRAST ENHANCEMENT; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRUG DISTRIBUTION; DRUG TISSUE LEVEL; DURA MATER; FEMALE; FIBROSIS; GRAFT FAILURE; HISTOCHEMISTRY; HISTOLOGY; HUMAN; HUMAN TISSUE; INTESTINE WALL; KIDNEY; LIVER; LUNG; LYMPH NODE; NEPHROGENIC SYSTEMIC FIBROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SKELETAL MUSCLE; SKIN; SKIN FISTULA;

ADULT; AUTOPSY; CALCINOSIS; CONTRAST MEDIA; FEMALE; FIBROSIS; GADOLINIUM DTPA; HUMANS; KIDNEY FAILURE, CHRONIC; NEPHROGENIC FIBROSING DERMOPATHY; PHOSPHATES; SKIN DISEASES; SPECTROMETRY, X-RAY EMISSION; TISSUE DISTRIBUTION;

EID: 80155146808     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr085     Document Type: Article

References (55)

1. Cowper SE, Su LD, Bhawan J et al. Nephrogenic fibrosing dermopathy. Am J Dermatopathol 2001; 23: 383-393
2. Ting WW, Stone MS, Madison KC et al. Nephrogenic fibrosing dermopathy with systemic involvement. Arch Dermatol 2003; 139: 903-906
3. Grobner T. Gadolinium-a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 2006; 21: 1104-1108
4. Marckmann P, Skov L, Rossen K et al. Nephrogenic systemic fibrosis: Suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 2006; 17: 2359-2362
5. High WA, Ayers RA, Chandler J et al. Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis. J Am Acad Dermatol 2007; 56: 21-26
6. Boyd AS, Zic JA, Abraham JL. Gadolinium deposition in nephrogenic fibrosing dermopathy. J Am Acad Dermatol 2007; 56: 27-30
7. Swaminathan S, High WA, Ranville J et al. Cardiac and vascular metal deposition with high mortality in nephrogenic systemic fibrosis. Kidney Int 2008; 73: 1413-1418
8. Kay J, Bazari H, Avery LL et al. Case records of the Massachusetts general hospital. Case 6-2008. A 46-year-old woman with renal failure and stiffness of the joints and skin. N Engl J Med 2008; 358: 827-838
9. Abraham JL, Thakral C, Skov L et al. Dermal inorganic gadolinium concentrations: Evidence for in vivo transmetallation and long-term persistence in nephrogenic systemic fibrosis. Br J Dermatol 2008; 158: 273-280
10. Marckmann P, Nielsen AH, Sloth JJ. Possibly enhanced Gd excretion in dialysate, but no major clinical benefit of 3-5 months of treatment with sodium thiosulfate in late stages of nephrogenic systemic fibrosis. Nephrol Dial Transplant 2008; 23: 3280-3282
11. Thakral C, Abraham JL. Automated scanning electron microscopy and x-ray microanalysis for in situ quantification of gadolinium deposits in skin. J Electron Microsc 2007; 56: 181-187
12. George SJ, Webb SM, Abraham JL et al. Synchrotron x-ray analyses demonstrate phosphate-bound gadolinium in skin in nephrogenic systemic fibrosis. Br J Dermatol 2010; 163(5):1077-1081
13. Edward M, Quinn JA, Burden AD et al. Effect of different classes of gadolinium based contrast agents on control and nephrogrnic systemic fibrosis-derived fibroblast proliferation. Radiology 2010; 3: 735-743
14. Li JX, Liu JC, Wang K et al. Gadolinium-containing bioparticles as an active entity to promote cell cycle progression in mouse embryo fibroblast NIH3T3 cells. J Biol Inorg Chem 2010; 15: 547-557
15. Edward M, Quinn JA, Mukherjee S et al. Gadodiamide contrast agent 'activates' fibroblasts: A possible cause of nephrogenic systemic fibrosis. J Pathol 2008; 214: 584-593
16. Vaidya VS, Ferguson MA, Bonventre JV. Biomarkers of acute kidney injury. Annu Rev Pharmacol Toxicol 2008; 48: 463-493
17. Marckmann P, Skov L, Rossen K et al. Case-control study of gadodiamide related nephrogenic systemic fibrosis. Nephrol Dial Transplant 2007; 22: 3174-3478
18. Song J, Volkov S, Shea CR et al. Nephrogenic systemic fibrosis associated with stromal and vascular calcification, report of two cases. J Cutan Pathol 2009; 36 (Suppl 1): S31-S34
19. Gou BD, Bian S, Zhang TL et al. Gadolinium-promoted precipitation of calcium phosphate is associated with profibrotic activation of RAW 264.7 macrophages. Toxicology In Vitro 2010; 24: 1743-1749
20. Ray DE, Holton JL, Nolan CC et al. Neurotoxic potential of gadodiamide after injection into the lateral cerebral ventricle of rats. AJNR Am J Neuroradiol 1998; 19: 1455-1462
21. Roman-Goldstein SM, Barnett PA, McCormick CI et al. Effects of gadopentetate dimeglumine administration after osmotic blood-brain barrier disruption: Toxicity and MR imaging findings. AJNR Am J Neuroradiol 1991; 12: 885-890
22. Lacour B, Lucas A, Auchére D et al. Chronic renal failure is associated with increased tissue deposition of lanthanum after 28-day oral administration. Kidney Int 2005; 67: 1062-1069
23. Maramattom BV, Manno EM, Wijdicks EF et al. Gadolinium encephalopathy in a patient with renal failure. Neurology 2005; 64: 1276-1278
24. Abdelbaqi-Salhab M, Shalhub S, Morgan MB. A current review of the cutaneous manifestations of renal disease. J Cutan Pathol 2003; 30: 527-538
25. Edsall LC, English JC 3rd, Teague MW et al. Calciphylaxis and metastatic calcification associated with nephrogenic fibrosing dermopathy. J Cutan Pathol 2004; 31: 247-253
26. Hutchins GM. Cardiac pathology in chronic renal failure. In: Parfrey PS, Harnett JD, eds. Cardiac Dysfunction in Chronic Uremia. Boston, MA: Kluwer Academic; 1992:85-104
27. Nowack R, Mandelbaum AP, Ritz E. Etiology of left ventricular dysfunction in end-stage renal failure. In: Parfrey PS, Harnett JD, eds. Cardiac Dysfunction in Chronic Uremia. Boston, MA: Kluwer Academic; 1992:105-115
28. Mall G, Rambausek M, Neumeister A et al. Myocardial interstitial fibrosis in experimental uremia-implications for cardiac compliance. Kidney Int 1988; 33: 804-811
29. Rossle H. Uber die serosen Entzundungen der Organe. Virchows Arch 1943; 311: 252-284
30. Langendorf R, Pirani CL. The heart in uremia. Am Heart J 1947; 33: 282-307
31. Mall G, Huther W, Schneider J et al. Diffuse intermyocardiocytic fibrosis in uraemic patients. Nephrol Dial Transplant 1990; 5: 39-44
32. Kuzela DC, Huffer WE, Conger JD et al. Soft tissue calcification in chronic dialysis patients. Am J Pathology 1977; 86: 403-424
33. Koreishi AF, Nazarian RM, Saenz AJ et al. Nephrogenic systemic fibrosis: A pathologic study of autopsy cases. Arch Pathol Lab Med 2009; 133: 1943-1948
34. Kucher C, Steere J, Elenistas R et al. Nephrogenic fibrosing dermopathy/ nephrogenic systemic fibrosis with diaphragmatic involvement in a patient with respiratory failure. J AmAcadDermatol 2006; 449: 389-391
35. Gibson SE, Farver CV, Prayson RA. Multiorgan involvement in nephrogenic fibrosing dermopathy: An autopsy case and review of the literature. Arch Pathol Lab Med 2006; 130: 209-212
36. DaramSR, Cortese CM, Bastani B.Nephrogenic fibrosing dermopathy/ nephrogenic systemic fibrosis: Report of a new case with literature review. Am J Kidney Dis 2005; 46: 754-779
37. Krous HF, Breisch E, Chadwick AE et al. Nephrogenic sytemic fibrosis with multiorgan involvement in a teenage male after lymphoma, Ewing's sarcoma, end-stage renal disease, and hemodialysis. Pediatr Dev Pathol 2007; 10: 395-402
38. Fairshter RD, Vaziri ND, Mirahmadi MK. Lung pathology in chronic hemodialysis patients. Int J Artif Organs 1982; 5: 97-100
39. Fairshter RD, Vaziri ND, Gordon S. Frequency and spectrum of pulmonary diseases in patients with chronic renal failure associated with spinal cord injury. Respiration 1983; 44: 58-62
40. Abraham JL, Narendra S, Davis RL. Pulmonary findings at autopsy in gadolinium-related nephrogenic systemic fibrosis. Am J Respir Crit Care Med 2010; 81: A1758
41. Jimenez SA, Arlett CM, Sandorfi N et al. Dialysis associated systemic fibrosis (nephrogenic fibrosing dermopathy): Study of inflammatory cells and transforming growth factor beta1 expression in affected skin. Arthritis Rheum 2004; 50: 2660-2666
42. Lazaro RP, Kirshner HS. Proximal muscle weakness in uremia. Case reports and review of the literature. Arch Neurol 1980; 37: 555-558
43. Levine JM, Taylor RA, Elman LB et al. Involvement of skeletal muscle in dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy). Muscle Nerve 2004; 30: 569-577
44. Ritchie WGM, Davison AM. Dural calcification: A complication of prolonged periodic haemodialysis. Clin Radiol 1974; 25: 349-353
45. Barber ND, Nakamoto S, McCormack LJ et al. Pathologic anatomy of 13 patients after prolonged periodic haemodialysis. Trans Am Soc Artif Intern Organs 1963; 9: 21-27
46. Dorenbeck U, Leingartner T, Bretschneider T et al. Tentorial and dural calcification with tertiary hyperparathyroidism: A rare entity in chronic renal failure. Eur Radiol 2002; 12: S11-S13
47. Zelasko S, Hollingshead M, Castillo M et al. CT and MR imaging of progressive dural involvement by nephrogenic systemic fibrosis. AJNR Am J Neuroradiol 2008; 29: 1880-1882
48. Spencer WH. Ophthalmic Pathology. 4th edn, Philadelphia, PA: WB Saunders Company; 1996. 337-340, 364
49. Streams BN, Liu V, Liegeois N et al. Clinical and pathologic features of nephrogenic fibrosing dermopathy: A report of two cases. J Am Acad Dermatol 2003; 48(1):42-47
50. Introcaso CE, Hivnor C, Cowper S et al. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: A case series of nine patients and review of the literature. Int J Dermatol 2007; 46: 447-452
51. Klintworth GK, Cummings TJ. Normal eye and ocular adnexa. In: Mills SE, ed. Histology for Pathologists. Philadelphia, PA: Lippincott Williams and Wilkins; 2007: 347-351
52. Barker-Griffith A, Goldberg J, Abraham JL. Ocular pathology and gadolinium deposition in nephrogenic systemic fibrosis. Arch Ophthalmol 2010; (in press)
53. Arieff AI. Nervous system manifestations of renal failure. In: Schrier RW, ed. Diseases of the Kidney and Urinary Tract. Philadelphia, PA: Lippincott Williams and Wilkins; 2007, pp. 2460-2481
54. Elias AN, Vaziri ND, Farooqui S et al. Pathology of endocrine organs in chronic renal failure-an autopsy analysis of 66 patients. Int J Art Organs 1984; 7: 251-256
55. Martin DR, Krishnamoorthy SK, Kalb B et al. Decreased incidence of NSF in patients on dialysis after changing gadolinium contrastenhanced MRI protocols. J Magn Reson Imaging 2010; 31: 440-446